Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Myelodysplastic Syndromes (MDS)
Cristina Astrid Tentori(IRCCS Humanitas Research Hospital), Najla H. Al Ali(Moffitt Cancer Center), Carmen Di Grazia(Ospedale Policlinico San Martino), Francisca Maria Hernandez(Hospital Universitario Virgen de las Nieves), Elisabetta Sauta(Humanitas University), Francesco Passamonti(University of Insubria), Marie Robin(Universität Hamburg), Saverio D’Amico(Humanitas University), Caterina Gregorio(University of Trieste), Victor Savevski(Humanitas University), Alessia Campagna(Humanitas University), Matteo Zampini(Humanitas University), Fabio Ciceri(San Antonio College), Erica Travaglino(Policlinico San Matteo Fondazione), Massimo Bernardi(Vita-Salute San Raffaele University), Luca Vago(Vita-Salute San Raffaele University), Marilena Bicchieri(Humanitas University), Somedeb Ball(Vanderbilt University), Manja Meggendorfer(Université Paris-Sud), Patrizia Chiusolo(Agostino Gemelli University Polyclinic), Stéfania Bramanti(Istituti di Ricovero e Cura a Carattere Scientifico), Benedetta Tinterri(Ministero della Salute), Daniele Mannina(Humanitas University), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Nico Gagelmann(Universität Hamburg), Carmelo Gurnari(University of Rome Tor Vergata), Gabriele Todisco(Humanitas University), Juan Carlos Caballero Berrocal(Complejo Hospitalario de Salamanca), Maria Teresa Voso(University of Rome Tor Vergata), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Lin‐Pierre Zhao, Filippo Viviani(Istituti di Ricovero e Cura a Carattere Scientifico), Marina Díaz‐Beyá(Hospital Clínic de Barcelona), Olivier Nibourel(Inserm), Marta Ubezio(Humanitas University), Giulia Rivoli(Ospedale Policlinico San Martino), Marta Spreafico(Leiden University), Luisa Giaccone(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jan Philipp Bewersdorf, Giulia Maggioni(Humanitas University), Andrés Jerez(Cleveland Clinic), Luca Lanino(Humanitas University), Gianluca Asti(IRCCS Humanitas Research Hospital), Alessandro Buizza(Istituti di Ricovero e Cura a Carattere Scientifico), Armando Santoro(IRCCS Humanitas Research Hospital), Antonio Russo(Humanitas University), Andrea Bacigalupo(Ospedale Policlinico San Martino), Elena Riva(Humanitas University), Lorenza Borin(Azienda Ospedaliera San Gerardo), Kyra Velázquez Kennedy(Instituto Cajal)
Cited by 5
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Somatic<i>SF3B1</i>Mutation in Myelodysplasia with Ring Sideroblasts
|New England Journal of Medicine|2011|1.2k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k